More common is malabsorption due to a number of gastrointestinal risk factors: Atrophic gastritis, which increases with age, impairs both the production of the acid and enzymes needed to break down food, and the production of intrinsic factor
In the STEP 1 trial, once-weekly 2.4mg semaglutide produced a mean 14.9% body-weight reduction over 68 weeks establishing GLP-1 agonism as a leading anti-obesity mechanism
But, as we've said, the mechanism is only part of the story
This translates to approximately 16-20 mg total during the loading period, with injections spaced 3-4 days apart for optimal distribution
Tidy up ageing narratives held in immune and nervous systems, shifting from Im decaying and vulnerable to I am renewing within the natural limits of my life path. Support those who have aged through chronic over-giving and over-adaptation to rebuild a more solid, dignified boundary